In Silico Designed Axl Receptor Blocking Drug Candidates Against Zika Virus Infection

In Silico Designed Axl Receptor Blocking Drug Candidates Against Zika Virus Infection

Bibliographic Details
Main Authors:	Edita Sarukhanyan, Sergey Shityakov, Thomas Dandekar
Format:	Article
Language:	English
Published:	American Chemical Society 2018-05-01
Series:	ACS Omega
Online Access:	http://dx.doi.org/10.1021/acsomega.8b00223

Similar Items

Rational Drug Design of Axl Tyrosine Kinase Type I Inhibitors as Promising Candidates Against Cancer
by: Edita Sarukhanyan, et al.
Published: (2020-02-01)

Loss of the TAM Receptor Axl Ameliorates Severe Zika Virus Pathogenesis and Reduces Apoptosis in Microglia
by: Andrew K. Hastings, et al.
Published: (2019-03-01)

In silico identification of drug candidates against COVID-19
by: Yifei Wu, et al.
Published: (2020-01-01)

In Silico Discovery of Candidate Drugs against Covid-19
by: Claudia Cava, et al.
Published: (2020-04-01)

In silico prediction of a highly immunogenic and conserved epitope against Zika Virus
by: Debasish Paul, et al.
Published: (2021-01-01)

Axl Promotes Zika Virus Entry and Modulates the Antiviral State of Human Sertoli Cells
by: Daniel P. Strange, et al.
Published: (2019-07-01)

Axl Mediates ZIKA Virus Entry in Human Glial Cells and Modulates Innate Immune Responses
by: Laurent Meertens, et al.
Published: (2017-01-01)

A genetically stable Zika virus vaccine candidate protects mice against virus infection and vertical transmission
by: Awadalkareem Adam, et al.
Published: (2021-02-01)

A single-dose live attenuated chimeric vaccine candidate against Zika virus
by: Wei-Xin Chin, et al.
Published: (2021-01-01)

In silico design of a Zika virus non-structural protein 5 aiming vaccine protection against zika and dengue in different human populations
by: Lorrany dos Santos Franco, et al.
Published: (2017-11-01)

The Role of Human AXL Receptor Tyrosine Kinase in Influenza A Virus Infection
by: Mei-Fang Hsu, et al.
Published: (2016)

In Silico Identification of New Targets for Diagnosis, Vaccine, and Drug Candidates against Trypanosoma cruzi
by: Rafael Obata Trevisan, et al.
Published: (2020-01-01)

In silico predictions of protein interactions between Zika virus and human host
by: João Luiz de Lemos Padilha Pitta, et al.
Published: (2021-08-01)

Zika virus proteins at an atomic scale: how does structural biology help us to understand and develop vaccines and drugs against Zika virus infection?
by: Ana Paula Valente, et al.

CD4+ T Cells Cross-Reactive with Dengue and Zika Viruses Protect against Zika Virus Infection
by: Jinsheng Wen, et al.
Published: (2020-04-01)

Improved Immune Responses Against Zika Virus After Sequential Dengue and Zika Virus Infection in Humans
by: Félix G. Delgado, et al.
Published: (2018-09-01)

The roles of receptor tyrosine kinase AXL in acute leukemia drug resistance
by: Chih-Chen Hong, et al.
Published: (2008)

TAM Receptors Are Not Required for Zika Virus Infection in Mice
by: Andrew K. Hastings, et al.
Published: (2017-04-01)

In silico designing of vaccine candidate against Clostridium difficile
by: Srijita Basak, et al.
Published: (2021-07-01)

Computational drug discovery for the Zika virus
by: Melina Mottin, et al.
Published: (2018-11-01)

Zika Virus Replicons for Drug Discovery
by: Xuping Xie, et al.
Published: (2016-10-01)

Sofosbuvir: an antiviral drug with potential efficacy against Zika infection
by: Sandra E. Reznik, et al.
Published: (2017-02-01)

Modulation of Dengue/Zika Virus Pathogenicity by Antibody-Dependent Enhancement and Strategies to Protect Against Enhancement in Zika Virus Infection
by: Rekha Khandia, et al.
Published: (2018-04-01)

Development of Small-Molecule Inhibitors Against Zika Virus Infection
by: Lili Wang, et al.
Published: (2019-12-01)

In Silico Screening of Natural Compounds for Candidates 5HT6 Receptor Antagonists against Alzheimer’s Disease
by: Bojić, T., et al.
Published: (2022)

In-silico design of envelope based multi-epitope vaccine candidate against Kyasanur forest disease virus
by: Sathishkumar Arumugam, et al.
Published: (2021-08-01)

Zika Virus Infection
by: I.B. Yershova, et al.
Published: (2016-04-01)

Mechanism of Action of Methotrexate Against Zika Virus
by: Sungjun Beck, et al.
Published: (2019-04-01)

Recombinant Zika virus envelope protein elicited protective immunity against Zika virus in immunocompetent mice.
by: Huabin Liang, et al.
Published: (2018-01-01)

Chloroquine, an Endocytosis Blocking Agent, Inhibits Zika Virus Infection in Different Cell Models
by: Rodrigo Delvecchio, et al.
Published: (2016-11-01)

Treatment of Human Glioblastoma with a Live Attenuated Zika Virus Vaccine Candidate
by: Qi Chen, et al.
Published: (2018-09-01)

Pathogen blocking in Wolbachia-infected Aedes aegypti is not affected by Zika and dengue virus co-infection.
by: Eric P Caragata, et al.
Published: (2019-05-01)

Personal protective measures of pregnant women against Zika virus infection
by: Vladimir Antonio Dantas Melo, et al.

In Silico, In Vitro and In Vivo Pharmacodynamic Characterization of Novel Analgesic Drug Candidate Somatostatin SST4 Receptor Agonists
by: Boglárka Kántás, et al.
Published: (2021-01-01)

T-cell Responses in Individuals Infected with Zika Virus and in Those Vaccinated Against Dengue Virus
by: Dominic Paquin-Proulx, et al.
Published: (2017-06-01)

The Receptor Tyrosine Kinase AXL in Cancer Progression
by: Erinn B. Rankin, et al.
Published: (2016-11-01)

Preconceptual Zika virus asymptomatic infection protects against secondary prenatal infection.
by: Lucien H Turner, et al.
Published: (2017-11-01)

Identification of Antifungal Targets Based on Computer Modeling
by: Elena Bencurova, et al.
Published: (2018-07-01)

Zika virus-like particle vaccine protects AG129 mice and rhesus macaques against Zika virus.
by: Lo Vang, et al.
Published: (2021-03-01)

Investigation of natural product B against Zika virus
by: Hsing-Ju Wu, et al.
Published: (2018)